SSC-ILD mouse model induced by osmotic minipump delivered bleomycin: effect of Nintedanib
Abstract Systemic sclerosis (SSc) is an autoimmune disease characterized by an excessive production and accumulation of collagen in the skin and internal organs often associated with interstitial lung disease (ILD). Its pathogenetic mechanisms are unknown and the lack of animal models mimicking the...
Guardado en:
Autores principales: | Francesca Ravanetti, Erica Ferrini, Luisa Ragionieri, Zahra Khalajzeyqami, Maria Nicastro, Yanto Ridwan, Alex Kleinjan, Gino Villetti, Andrea Grandi, Franco Fabio Stellari |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c97189aa45ba426ca1dc74f514bdf894 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High-Resolution Computed Tomography: Lights and Shadows in Improving Care for SSc-ILD Patients
por: Barbara Ruaro, et al.
Publicado: (2021) -
Equilibrating SSC guidelines with individualized care
por: Jean-Louis Vincent, et al.
Publicado: (2021) -
Emerging treatments and combinations in the management of NSCLC: clinical potential of nintedanib
por: Reck M, et al.
Publicado: (2015) -
Clinical development of nintedanib for advanced non-small-cell lung cancer
por: Takeda M, et al.
Publicado: (2015) -
Autoantibodies to estrogen receptor α in systemic sclerosis (SSc) as pathogenetic determinants and markers of progression.
por: Antonello Giovannetti, et al.
Publicado: (2013)